Completed × NETWORK × Squamous Cell Carcinoma of Head and Neck × Clear all Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 3 Completed
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
Phase 3 Completed
987 enrolled 59 charts
Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
320 enrolled 13 charts
Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
19 enrolled
Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Head and Neck Cancer
Phase 3 Completed
743 enrolled 16 charts
Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
69 enrolled 7 charts
Analysis of Tumor Tissue and Lymph Nodes Surgically Removed From Patients With Cancers of the Head and Neck
Completed
530 enrolled
Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
230 enrolled
Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
Phase NA Completed
434 enrolled
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
Phase 2 Completed
Isotretinoin, Interferon Alfa, and Vitamin E in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
940 enrolled 19 charts
Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck Cancer
Phase 3 Completed
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
Phase 2 Completed
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
Phase 1/2 Completed
Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
Phase 3 Completed
Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
Phase 2 Completed
49 enrolled 13 charts
Adjuvant Cetuximab and Chemoradiotherapy Using Either Cisplatin or Docetaxel in Treating Patients With Resected Stage III or Stage IV Squamous Cell Carcinoma or Lymphoepithelioma of the Head and Neck
Phase 2 Completed
238 enrolled 12 charts
Combination Chemotherapy Plus Radiation Therapy To Preserve the Larynx in Patients With Cancer of the Hypopharynx or Larynx
Phase 3 Completed
564 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
359 enrolled
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
Phase 1/2 Completed
7 enrolled
Neoadjuvant Afatinib Window Study in Squamous Cell Carcinoma of the Head and Neck
Phase 2 Completed
30 enrolled
DAHANCA 28A: Phase I/II Study on Accelerated, Hyperfractionated Radiotherapy With Concomitant Cisplatin and Nimorazole
Phase 1/2 Completed
31 enrolled
Biomarkers in Patients With Head and Neck Cancer
Completed
70 enrolled
Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck Cancer
Completed
30 enrolled
Biomakers in Tissue Samples From Patients With Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck Previously Treated With Cisplatin With or Without Cetuximab
Completed
79 enrolled
Biomarkers of Response in Blood and Tumor Tissue Samples From Patients With Unresectable Stage IV Squamous Cell Cancer of the Head and Neck Previously Treated With Cetuximab, Cisplatin, and Radiation Therapy
Completed
69 enrolled
Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397
Completed
42 enrolled
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
Completed
155 enrolled
Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial
Completed
183 enrolled
Radiation Therapy in Treating Patients With Stage II Cancer of the Vocal Cord
Phase 3 Completed
250 enrolled
Pilocarpine in Preventing Mucositis and Dry Mouth in Patients Receiving Radiation Therapy for Head and Neck Cancer
Phase 3 Completed
249 enrolled
Paclitaxel, Cisplatin, and Filgrastim Combined With Radiation Therapy in Treating Patients With Locally Recurrent Head and Neck Cancer
Phase 2 Completed
105 enrolled
Chemotherapy and Radiation Therapy Following Surgery in Treating Patients With Head and Neck Cancer
Phase 2 Completed
70 enrolled
Collecting and Storing Tissue Samples From Patients With Head and Neck Cancer
Completed
351 enrolled
Customized Headrest or Standard Headrest in Holding Patients Still While Undergoing Radiation Therapy for Head and Neck Cancer
Phase NA Completed
40 enrolled
Cisplatin and Radiation Therapy in Treating Patients With Stage IV Cancer of the Head and Neck
Phase 2 Completed
60 enrolled
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Cancer of the Larynx
Phase 3 Completed
Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer That Has Been Removed During Surgery
Phase 3 Completed
459 enrolled
Fractionated Radiation Therapy in Treating Advanced Squamous Cell Carcinoma of the Head and Neck
Phase 3 Completed
1,113 enrolled
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Phase 2 Completed
76 enrolled
S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 2 Completed
68 enrolled
S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 2 Completed
78 enrolled
NGR-TNF in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
70 enrolled
Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Phase 2 Completed
50 enrolled
High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
Phase 3 Completed
338 enrolled
Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases
Phase 1 Completed
27 enrolled
S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed